Literature DB >> 8432838

Immune response against lipopolysaccharide and invasion plasmid-coded antigens of shigellae in Vietnamese and Swedish dysenteric patients.

P D Cam1, T Pál, A A Lindberg.   

Abstract

The peripheral immune responses of adult Vietnamese patients infected with Shigella dysenteriae 1 and Shigella flexneri 1b and 2a and those of S. flexneri-infected Swedish patients were studied against various lipopolysaccharide and invasion plasmid-coded antigens (Ipa-s) and compared with the titers for the corresponding local healthy populations. Both Vietnamese and Swedish patients reacted with significant (P, < 0.05) titer increases in the immunoglobulin A and G classes against the homologous lipopolysaccharide antigen. However, significant titer responses against the Ipa-s were seen among only the Swedish patients. We surmise that the weak-to-moderate responses against the Ipa-s in Vietnamese patients are due to the fact that the high level of titers induced by previous infections in the local population could not be considerably increased further by a recent infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432838      PMCID: PMC262788          DOI: 10.1128/jcm.31.2.454-457.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers.

Authors:  A Li; T Pál; U Forsum; A A Lindberg
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Localization of plasmid loci necessary for the entry of Shigella flexneri into HeLa cells, and characterization of one locus encoding four immunogenic polypeptides.

Authors:  B Baudry; A T Maurelli; P Clerc; J C Sadoff; P J Sansonetti
Journal:  J Gen Microbiol       Date:  1987-12

3.  Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections.

Authors:  D Cohen; C Block; M S Green; G Lowell; I Ofek
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

4.  Local and systemic antibody responses to Shigella infection in rhesus monkeys.

Authors:  G Dinari; T L Hale; S W Austin; S B Formal
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

5.  IgG response of dysenteric patients to antigens coded by the virulence plasmid of enteroinvasive pathogens.

Authors:  T Pál; G Brasch
Journal:  Acta Microbiol Hung       Date:  1987

Review 6.  Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays.

Authors:  A A Lindberg; P D Cam; N Chan; L K Phu; D D Trach; G Lindberg; K Karlsson; A Kärnell; E Ekwall
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

7.  The humoral antibody response to Shigella dysenteriae type 1 infection, as determined by ELISA.

Authors:  A A Lindberg; S Haeggman; K Karlsson; D C Phung; D T Dang
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

8.  Identification and antigenic characterization of virulence-associated, plasmid-coded proteins of Shigella spp. and enteroinvasive Escherichia coli.

Authors:  T L Hale; E V Oaks; S B Formal
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Molecular cloning of invasion plasmid antigen (ipa) genes from Shigella flexneri: analysis of ipa gene products and genetic mapping.

Authors:  J M Buysse; C K Stover; E V Oaks; M Venkatesan; D J Kopecko
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

10.  Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp.

Authors:  E V Oaks; T L Hale; S B Formal
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

View more
  14 in total

Review 1.  Vaccines against human diarrheal pathogens: current status and perspectives.

Authors:  Nathalie Böhles; Nathalie Böhles; Kim Busch; Kim Busch; Michael Hensel; Michael Hensel
Journal:  Hum Vaccin Immunother       Date:  2014-05-26       Impact factor: 3.452

2.  Immune response to Shigella sonnei in U.S. Marines.

Authors:  M M Mikhail; M M Mansour; B A Oyofo; J D Malone
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

3.  Selective deletion of CD8(+) cells upregulated by caspases-1 via IL-18 in mice immunized with major outer membrane protein of Shigella dysenteriae 1 following infection.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Pradip Maiti; Joydeep Mukherjee; Arpita Panda; Dhira Rani Saha
Journal:  J Clin Immunol       Date:  2010-01-19       Impact factor: 8.317

4.  Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea.

Authors:  Anuradha Sinha; Ayan Dey; Giulietta Saletti; Pradip Samanta; Partha Sarathi Chakraborty; M K Bhattacharya; Santanu Ghosh; T Ramamurthy; Jae-Ouk Kim; Jae Seung Yang; Dong Wook Kim; Cecil Czerkinsky; Ranjan K Nandy
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

5.  Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis.

Authors:  D Islam; B Wretlind; M Ryd; A A Lindberg; B Christensson
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

6.  Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a.

Authors:  Rezwanul Wahid; Jakub K Simon; Wendy L Picking; Karen L Kotloff; Myron M Levine; Marcelo B Sztein
Journal:  Clin Immunol       Date:  2013-03-26       Impact factor: 3.969

7.  Broadly protective Shigella vaccine based on type III secretion apparatus proteins.

Authors:  Francisco J Martinez-Becerra; Julian M Kissmann; Jovita Diaz-McNair; Shyamal P Choudhari; Amy M Quick; Gabriela Mellado-Sanchez; John D Clements; Marcela F Pasetti; Wendy L Picking
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

8.  Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study.

Authors:  Avital A Shimanovich; Amanda D Buskirk; Shannon J Heine; William C Blackwelder; Rezwanul Wahid; Karen L Kotloff; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

9.  Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.

Authors:  Shannon J Heine; Jovita Diaz-McNair; Francisco J Martinez-Becerra; Shyamal P Choudhari; John D Clements; Wendy L Picking; Marcela F Pasetti
Journal:  Vaccine       Date:  2013-05-02       Impact factor: 3.641

10.  The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants.

Authors:  Corinne N Thompson; Thi Phuong Tu Le; Katherine L Anders; Trong Hieu Nguyen; Lan Vi Lu; Van Vinh Chau Nguyen; Thuy Duong Vu; Ngoc Minh Chau Nguyen; Thi Hong Chau Tran; Thanh Tuyen Ha; Vu Thieu Nga Tran; Van Minh Pham; Do Hoang Nhu Tran; Thi Quynh Nhi Le; Allan Saul; Laura B Martin; Audino Podda; Christiane Gerke; Guy Thwaites; Cameron P Simmons; Stephen Baker
Journal:  Vaccine       Date:  2015-12-29       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.